AMBIZYGO : étude de phase II de l’efficacité d’une posologie initiale élevée d’amphotéricine B liposomale (AmBisome®) [10 mg/kg/j] dans le traitement des zygomycoses
AMBIZYGO : étude de phase II de l’efficacité d’une posologie initiale élevée d’amphotéricine B liposomale (AmBisome®) [10 mg/kg/j] dans le traitement des zygomycoses
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started